This inventor holds 2 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1995-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2023
Title: **Innovative Contributions of Makoto Ishii**
Introduction
Makoto Ishii is an accomplished inventor based in Kawasaki, Japan, known for his significant contributions to the field of medical and pharmaceutical innovations. With a total of two patents to his name, his work demonstrates a commitment to advancing the understanding and treatment of pain and cancer.
Latest Patents
Ishii's recent patents include a novel composition for preventing or improving nociceptive pain. This composition comprises an amino acid featuring serine and a lipid containing at least one n-3 fatty acid, showing promise as a therapeutic agent for pain management. Additionally, he has developed anisomycin derivatives that serve as anticancer and antifungal agents. These derivatives are characterized by specific structural formulas that enhance their stability in blood or plasma, making them valuable candidates for various medical applications.
Career Highlights
Throughout his career, Makoto Ishii has been affiliated with Ajinomoto Co., Ltd., a leading company renowned for its research and development in food products and pharmaceuticals. His work at Ajinomoto showcases his dedication to improving health outcomes through innovative solutions.
Collaborations
Ishii collaborates with esteemed colleagues such as Yukio Iino and Koji Ohsumi, contributing to a rich environment of innovation and research. Their teamwork amplifies the potential for breakthroughs in their respective fields, particularly in the development of new therapeutic agents.
Conclusion
In summary, Makoto Ishii's exemplary work as an inventor, along with his latest patents and collaborations, reinforces his impact in the pharmaceutical and medical sectors. His innovative contributions continue to pave the way for advancements in pain management and cancer treatment, highlighting the importance of research and development in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
